STOCK MARKET BSE NSE

Cancer over-care by up to whooping 250 per cent in private hospitals, says study

This finding has raised concerns about possible over-treatment of cancer patients to make more money under the Pradhan Mantri Jan Aarogya Yojana (PMJAY) scheme.

Published: 21st November 2019 03:17 AM  |   Last Updated: 21st November 2019 10:07 AM   |  A+A-

medicine, medical field, doctors

For representational purposes

Express News Service

NEW DELHI: An internal analysis of cancer care offered under the Centre’s big-ticket health insurance scheme Pradhan Mantri Jan Aarogya Yojana (PMJAY) has shown that the average claim size for various oncology packages is far higher — by up to 250 per cent — in private hospitals as compared to government hospitals.

This finding has raised concerns about possible over-treatment of cancer patients to make more money under the scheme through which hospitalisation benefits of up to Rs 5 lakh is given to a large number of poor patients across the country.

The assessment of oncology package utilization from September 2018, when the scheme was launched, to July this year showed that the average claim size was nearly 113-250 per cent higher in private hospitals in case of surgical procedures, 94-113 per cent higher in case of radiology and 66% higher in case of medical oncology.

Oncology comprised 9 per cent of total claims submitted, and 34 per cent of all tertiary claims submitted with two states — Tamil Nadu and Maharashtra generating 60 per cent of all oncology claims.

The variations were noticed in the proportion of average claim size across states and within the states — between public and private.

“Profit motive is a big and undeniable agenda for a large number of private hospitals and that could explain the trend,” said Pritam Datta, a fellow in health economics with the National Institute of Public Finance and Policy.

Concerned with the findings, the National Health Authority — which implements the PMJAY— has already begun talks with the National Cancer Grid to ensure that there is no under or over-treatment for the disease.

“We will soon find a way to ensure quality and standardized course of treatment under the scheme,” said a senior NHA official.

The assessment has said that the major reason for the differentials in any of the categories may reflect due to case mix -two or more packages combined and two or more packages claimed for the same beneficiaries.

“The stark variations between private and public hospitals within the states raises issues like cost of health product — covering treatment, surgeons fees, physiological care — or the provider induced demand,” the assessment has also noted.

Provider induced demand is often described as a big problem in health care that involves influencing the consumption of healthcare by medical professionals through increased procedures, more complex procedures or both.

Sukhvinder Kaur, a consultant with NHA who was a co-author of the analysis, however, said that state data needs to be examined further to draw conclusive inferences.

Sudhakar Shinde, CEO of Maharashtra State Health Authority said that standard treatment protocols were a must for cancer packages.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp